ARZNEIMITTEL ENTHALTEND LAMOTRIGIN
European patent · EP0833640 · Deleted
Register entry
- Publication number
- EP0833640
- Application number
- EP96923914
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Jun 20, 1996
- Published
- Apr 8, 1998
- Granted
- Dec 4, 2002
- Deleted
- Jun 30, 2009
- Reason
- Annual fee unpaid
- IPC classes
- A61K 31/53 (2006.01)A61K 9/14 (2006.01)A61K 9/19 (2006.01)
- Priority
- GB 9512854 23.06.1995
- PCT application
- PCT/EP1996/002759 20.06.1996
- PCT publication
- WO1997/000681 09.01.1997
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jan 20, 2010
Deleted, fee unpaid
Published in Swissreg on 20.01.2010
- Oct 15, 2007
Address changed
- Representative
- E. Blum & Co. Patentanwälte, Am Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich
Published in +pat+ No 19 in 2007
- Mar 14, 2003
Agent entered
- Representative
- E. Blum & Co. Patentanwälte, Am Vorderberg 11, 8044 Zürich
Published in +pat+ No 5 in 2003
- Dec 13, 2002
Granted
Published in +pat+ No 23 in 2002
Parties
Inventor
FLOYD, Alison, Green-Glaxo Wellcome Inc.
Research Triangle Park, NC 27709, US
JAIN, Sunil-Glaxo Wellcome Inc.
Research Triangle Park, NC 27709, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.